ONESOURCE — Onesource Specialty Pharma Cashflow Statement
0.000.00%
- IN₹209.64bn
- IN₹215.65bn
- IN₹14.45bn
Annual cashflow statement for Onesource Specialty Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -4,156 | -3,657 | -671 |
| Depreciation | |||
| Non-Cash Items | 1,061 | 1,672 | 1,522 |
| Discontinued Operations | |||
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 326 | -41.3 | -4,269 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -1,628 | -1,072 | -678 |
| Capital Expenditures | -440 | -638 | -1,281 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -238 | 5,743 | -729 |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Change in Net Intangibles | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -678 | 5,105 | -2,011 |
| Financing Cash Flow Items | -1,053 | -1,033 | -1,565 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1,183 | -3,905 | 4,120 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -1,123 | 128 | 1,431 |